Phenol 2% in Compound zinc paste
Requires a prescription from a doctor or prescriber
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 5 · 2001–2026
Showing the 50 most relevant studies, sorted by most relevant.
Bircan Dindar, S. Icli
Journal of Photochemistry and Photobiology A-chemistry, 2001
S. Anju, S. Yesodharan, E. Yesodharan
Chemical Engineering Journal, 2012
A. Abdelaziz, S. Salem, A. Khalil, et al.
Biometals, 2022
Aftab M, Haq Khan ZU, Shah NS, et al.
2025
The widespread use and persistence of pesticides in aquatic environments pose a severe risk to ecosystems and human health. This review comprehensively analyses advanced oxidation processes (AOPs) for pesticide degradation, focusing on and persulfate activation mediated by nano zero-valent metals (nZVMs). Recent studies highlight the exceptional performance of nano zero-valent iron (nZVI), zinc (nZVZn), and copper (nZVCu) in generating reactive oxygen species (ROS) such as hydroxyl and sulfate radicals that effectively degrade persistent organic pollutants, including chlorpyrifos, atrazine, and p-chlorophenol. The paper further examines the mechanisms underlying pollutant degradation, the effects of operational parameters such as pH, oxidant and catalyst dosage, and the synergistic role of composite systems like nZVI/BC and nZVZn/PMS. In addition, degradation pathways and mineralization efficiencies are discussed in detail, providing insight into the reaction kinetics and mechanistic transformations of target pollutants. This review not only summarizes the advantages of integrating persulfate-based AOPs with nZVM catalysts but also identifies key challenges such as catalyst recovery, secondary pollution, and scalability. Overall, the findings provide a framework for advancing sustainable, efficient, and eco-friendly AOP-based technologies for pesticide remediation.
Abstract licence: CC BY
Alameh Babajani, A. Iranbakhsh, Z. Oraghi Ardebili, et al.
Environmental Science and Pollution Research, 2019
Matinise N
2025
Ruixing Li, S. Yabe, M. Yamashita, et al.
Materials Chemistry and Physics, 2002
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.